SSRI-induced parkinsonism may be an early sign of future Parkinson's disease
Gönül, A.S.; Aksu, M.
Journal of Clinical Psychiatry 60(6): 410
1999
ISSN/ISBN: 0160-6689 PMID: 10401924 Document Number: 500320
Document emailed within 1 workday
Related Documents
Scott, R.M.; Brody, J.A. 1970: Benign early-onset Parkinson's disease: a syndrome distinct from classic postencephalitic parkinsonism Neurology 20(4): 400Yasuda, T.; Yanagi, T.; Kawai, K. 1985: R-R interval variations in Parkinson's disease and vascular parkinsonism Rinsho Shinkeigaku 25(9): 1046-1051
Nagatsu, T.; Ichinose, H. 1997: GTP cyclohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson's disease Journal of Neural Transmission. Supplementum 49: 203-209
Tsunemi, T.; Hattori, N. 2017: The past changes and future perspectives on Parkinson's disease therapeutics in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 75(1): 14-20
Yang, X.M.; Hu, M.H.; Xie, Y.C.; Yan, H.Z.; Liu, H.R.; Wang, D.T.; Stark, P. 1990: Vacuole sign and nodule sign in early peripheral bronchogenic carcinoma. Diagnostic value and pathologic correlation Der Radiologe 30(4): 169-171
Oleínik, L.I. 1972: Parkinson's diseases and parkinsonism Meditsinskaia Sestra 31(9): 27-30
Jankovic, J. 2001: Parkinson's disease therapy: treatment of early and late disease Chinese Medical Journal 114(3): 227-234
Hornykiewicz, O. 2001: Dopamine and Parkinson's disease. a personal view of the past, the present, and the future Advances in Neurology 86: 1-11
Hofmann, M.; Vidoni, F. 1996: SSRI-induced akathesia Psychiatrische Praxis 23(3): 143-144
Dickerson, L.M.; Young, S.E.; Simpson, W.M.; Nashelsky, J. 2005: Treatment of early Parkinson's disease American Family Physician 72(3): 497-500
Stacy, M.; Brownlee, H.J. 1996: Treatment options for early Parkinson's disease American Family Physician 53(4): 1281-1287
Monji, A.; Yanagimoto, K.; Yoshida, I.; Hashioka, S. 2004: SSRI-induced enuresis: a case report Journal of Clinical Psychopharmacology 24(5): 564-565
Marttila, R. 2004: Which drug to use for the initiation of treatment for early Parkinson's disease Duodecim; Laaketieteellinen Aikakauskirja 120(5): 587-590
Katunina, E.A.; Titova, N.V.; Avakian, G.N. 2010: Methods of diagnosis early stage Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(12): 112-118
Petit, H. 1984: Early or late dopa therapy in Parkinson's disease Presse Medicale 13(36): 2213
Csanda, E.; Tárczy, M. 1987: Selegiline in the early and late phases of Parkinson's disease Journal of Neural Transmission. Supplementum 25: 105-113
Friedman, J. 1986: Recent research advances in Parkinson's disease: Part II. Studies in lower animals indicate a future for brain implants Rhode Island Medical Journal 69(8): 361-363
García de Yébenes, J.; Bazán, E.; Mena, M.A.; Muradas, V.; Reiriz, J.; Romero, J.; González-Elipe, J. 1986: Clinical and biochemical aspects of early-onset Parkinson's disease Revista Clinica Espanola 178(7): 343-346
Olanow, C.Warren. 2002: The role of dopamine agonists in the treatment of early Parkinson's disease Neurology 58(4 Suppl 1): S33-S41
Broussolle, E. 2000: Dopa-therapy in the treatment of early stage Parkinson's disease Revue Neurologique (Paris) 156(2 Part 2): 91-97